Periocular triamcinolone acetonide injections for control of intraocular inflammation associated with uveitis.
Ocul Immunol Inflamm
; 21(4): 257-63, 2013 Aug.
Article
em En
| MEDLINE
| ID: mdl-23617776
ABSTRACT
PURPOSE:
To describe the effectiveness of periocular corticosteroid injections for the control of intraocular inflammation associated with noninfectious uveitis.METHODS:
A total of 81 patients (109 eyes) who received a periocular injection were evaluated for active inflammation, visual acuity, intraocular pressure, degree of intraocular inflammation, and the presence of ocular complications, including macular edema.RESULTS:
Of all eyes, 36% (95%CI 25%, 45%) demonstrated clinical resolution of inflammation at the 1-month visit after first injection, and 48% (95%CI 37%, 59%) at 3 months. For multiple injections, 50% (95%CI 28%, 72%) demonstrated resolution of inflammation at 1 month after the last injection, and 41% (95%CI 20%, 63%) resolution of inflammation at 3 months after the last injection. Of the 49 eyes that initially responded, the estimated median time to recurrence was 7.6 months.CONCLUSIONS:
Approximately half of the treated eyes had resolution of intraocular inflammation at 3 months after corticosteroid injection.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Uveíte
/
Triancinolona Acetonida
Tipo de estudo:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adolescent
/
Adult
/
Aged
/
Child
/
Child, preschool
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Ocul Immunol Inflamm
Ano de publicação:
2013
Tipo de documento:
Article